NeuroSense Therapeutics Ltd - Warrants (09/11/2026) Accounts Payable

As of the most recent data (December 2025), NRSNW shows a accounts payable of $800K. That compares with $1.2M in the prior-year period — down 31.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NRSNW's accounts payable is now $800K (was $1.2M) — a 31.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether NeuroSense Therapeutics Ltd - Warrants (09/11/2026) is outperforming or lagging.

Tracking NRSNW's accounts payable over time shows whether NeuroSense Therapeutics Ltd - Warrants (09/11/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $800K That compares with $1.2M in the prior-year period — down 31.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has NeuroSense Therapeutics Ltd - Warrants (09/11/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $800K) with ownership activity and broader fundamentals.